These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25025339)

  • 1. Comparing binding modes of analogous fragments using NMR in fragment-based drug design: application to PRDX5.
    Aguirre C; ten Brink T; Guichou JF; Cala O; Krimm I
    PLoS One; 2014; 9(7):e102300. PubMed ID: 25025339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protein-ligand structure guided by backbone and side-chain proton chemical shift perturbations.
    Aguirre C; ten Brink T; Cala O; Guichou JF; Krimm I
    J Biomol NMR; 2014 Nov; 60(2-3):147-56. PubMed ID: 25256941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saturation transfer difference NMR for fragment screening.
    Begley DW; Moen SO; Pierce PG; Zartler ER
    Curr Protoc Chem Biol; 2013; 5(4):251-268. PubMed ID: 24391096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ligand-Orientation Based Fragment Selection in STD NMR Screening.
    Cala O; Krimm I
    J Med Chem; 2015 Nov; 58(21):8739-42. PubMed ID: 26492576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of fragment molecules that bind the human peroxiredoxin 5 active site.
    Barelier S; Linard D; Pons J; Clippe A; Knoops B; Lancelin JM; Krimm I
    PLoS One; 2010 Mar; 5(3):e9744. PubMed ID: 20305821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BcL-xL conformational changes upon fragment binding revealed by NMR.
    Aguirre C; Ten Brink T; Walker O; Guillière F; Davesne D; Krimm I
    PLoS One; 2013; 8(5):e64400. PubMed ID: 23717610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. STD-NMR experiments identify a structural motif with novel second-site activity against West Nile virus NS2B-NS3 protease.
    Schöne T; Grimm LL; Sakai N; Zhang L; Hilgenfeld R; Peters T
    Antiviral Res; 2017 Oct; 146():174-183. PubMed ID: 28927677
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fragment-based discovery of novel thymidylate synthase leads by NMR screening and group epitope mapping.
    Begley DW; Zheng S; Varani G
    Chem Biol Drug Des; 2010 Sep; 76(3):218-33. PubMed ID: 20626411
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Counting on Fragment Based Drug Design Approach for Drug Discovery.
    Kashyap A; Singh PK; Silakari O
    Curr Top Med Chem; 2018; 18(27):2284-2293. PubMed ID: 30499406
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives on Fragment-based Drug Discovery: A Strategy Applicable to Diverse Targets.
    Li Q; Kang C
    Curr Top Med Chem; 2021; 21(13):1099-1112. PubMed ID: 34348623
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advancing fragment binders to lead-like compounds using ligand and protein-based NMR spectroscopy.
    Maurer T
    Methods Enzymol; 2011; 493():469-85. PubMed ID: 21371602
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential Epitope Mapping by STD NMR Spectroscopy To Reveal the Nature of Protein-Ligand Contacts.
    Monaco S; Tailford LE; Juge N; Angulo J
    Angew Chem Int Ed Engl; 2017 Nov; 56(48):15289-15293. PubMed ID: 28977722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ranking Hits From Saturation Transfer Difference Nuclear Magnetic Resonance-Based Fragment Screening.
    Aretz J; Rademacher C
    Front Chem; 2019; 7():215. PubMed ID: 31032246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is NMR Fragment Screening Fine-Tuned to Assess Druggability of Protein-Protein Interactions?
    Dias DM; Van Molle I; Baud MG; Galdeano C; Geraldes CF; Ciulli A
    ACS Med Chem Lett; 2014 Jan; 5(1):23-28. PubMed ID: 24436777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complete relaxation and conformational exchange matrix (CORCEMA) analysis of intermolecular saturation transfer effects in reversibly forming ligand-receptor complexes.
    Jayalakshmi V; Krishna NR
    J Magn Reson; 2002 Mar; 155(1):106-18. PubMed ID: 11945039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMR-based screening methods for lead discovery.
    Vogtherr M; Fiebig K
    EXS; 2003; (93):183-202. PubMed ID: 12613177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recombinant Kinase Production and Fragment Screening by NMR Spectroscopy.
    Han B; Ahn HC
    Methods Mol Biol; 2016; 1360():35-46. PubMed ID: 26501900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NMR Fragment-Based Screening against Tandem RNA Recognition Motifs of TDP-43.
    Nshogoza G; Liu Y; Gao J; Liu M; Moududee SA; Ma R; Li F; Zhang J; Wu J; Shi Y; Ruan K
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31262091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. NMR characterization of weak interactions between RhoGDI2 and fragment screening hits.
    Liu J; Gao J; Li F; Ma R; Wei Q; Wang A; Wu J; Ruan K
    Biochim Biophys Acta Gen Subj; 2017 Jan; 1861(1 Pt A):3061-3070. PubMed ID: 27721047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Target immobilization as a strategy for NMR-based fragment screening: comparison of TINS, STD, and SPR for fragment hit identification.
    Kobayashi M; Retra K; Figaroa F; Hollander JG; Ab E; Heetebrij RJ; Irth H; Siegal G
    J Biomol Screen; 2010 Sep; 15(8):978-89. PubMed ID: 20817886
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.